Combined Effects of Alcohol and Caffeine
Information source: Johns Hopkins University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Alcohol or Other Drugs Effects
Intervention: Alcohol + Caffeine Beverage (Drug); Alcohol + Caffeine-placebo (Drug)
Phase: Phase 1
Status: Active, not recruiting
Sponsored by: Johns Hopkins University Official(s) and/or principal investigator(s): Roland R Griffiths, Ph.D., Principal Investigator, Affiliation: Johns Hopkins University
Summary
The purpose of this study is to investigate the effects of caffeine on the
self-administration of alcohol. The study will also examine the combined effects of alcohol
and caffeine on behavioral performance, participant ratings of behavioral performance, and
self-reported subjective effects.
Clinical Details
Official title: Combined Effects of Alcohol and Caffeine
Study design: Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science
Primary outcome: Total beverage consumed
Secondary outcome: Circular Lights TaskThe Biphasic Alcohol Effects Scale Expired air breath alcohol measures Subjective ratings 9-point likert scale Subjective ratings visual analogue scale
Detailed description:
The purpose of this study is to examine the effects of caffeine on alcohol
self-administration. Volunteers will participate in 7 experimental sessions in which they
will be given the opportunity to self-administer an alcohol + caffeine or alcohol +
caffeine-placebo beverage. The first 6 sessions will involve exposure to the two beverage
conditions in mixed order three times each (e. g., A, B, B, A, A, B). The seventh session
will be a choice session in which the participant will make a single choice at the beginning
of the session about which beverage they will consume that day. In addition to the primary
outcomes of quantity of alcohol self-administered and beverage choice, three additional
outcomes will be measured including: 1). indirect measures of reinforcing effects (e. g.
subjective ratings of liking, well-being, take again); 2). an alcohol-sensitive behavioral
measure; and 3). participant ratings of degree of behavioral impairment.
Eligibility
Minimum age: 21 Years.
Maximum age: 50 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Very light or moderate consumer of caffeine (either daily or non-daily).
- Social drinker of alcohol.
- Has experience in lifetime of heavy alcohol consumption.
- Read, write, and speak English fluently.
Exclusion Criteria:
- Serious and unstable illnesses including current hepatic, renal, gastroenterologic,
respiratory, cardiovascular (including ischemic heart disease, uncontrolled
hypertension, and congestive heart failure), endocrinologic, neurologic (including
stroke, transient ischemic attack, subarachnoidal bleeding, brain tumor,
encephalopathy, and meningitis), or hematologic disease.
- Parkinson's disease, seizure disorder, or history of significant head trauma.
- Current psychiatric illness
- Pregnant or nursing women or women who are not using an effective means of birth
control.
Locations and Contacts
Behavioral Pharmacology Research Unit, Baltimore, Maryland 21224, United States
Additional Information
Starting date: January 2011
Last updated: March 30, 2015
|